drugset / Trial / NCT01238965

Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy

NCT01238965

NaSingle-groupOpen-labelTreatment

Summary

Panobinostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as fluorouracil and leucovorin calcium, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving panobinostat together with fluorouracil and leucovorin calcium may kill more tumor cells. PURPOSE: This phase I trial is studying the side effects and the best dose of giving panobinostat, fluorouracil, and leucovorin calcium together in treating patients with stage IV colorectal cancer who did not respond to previous fluorouracil-based chemotherapy.

Timeline

Start
2010-10
Primary completion
2014-12
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Leucovorin Small molecule Intravenous
Subject Panobinostat Small molecule Oral
Subject fluorouracil Small molecule Intravenous

Indications